{
    "1666414206072107011": {
        "author_id": "5383942",
        "created_at": "2023-06-07T11:58:01.000Z",
        "edit_history_tweet_ids": [
            "1666414206072107011"
        ],
        "entities": {
            "hashtags": [
                {
                    "end": 147,
                    "start": 130,
                    "tag": "BehindTheScience"
                }
            ],
            "urls": [
                {
                    "display_url": "gsk.com/en-gb/behind-t\u2026",
                    "end": 273,
                    "expanded_url": "https://www.gsk.com/en-gb/behind-the-science-magazine/new-technology-drug-targets-rna-medicine-development/",
                    "start": 250,
                    "status": 200,
                    "unwound_url": "https://www.gsk.com/en-gb/behind-the-science-magazine/new-technology-drug-targets-rna-medicine-development/",
                    "url": "https://t.co/38nC4tEyuN"
                }
            ]
        },
        "id": "1666414206072107011",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 6557,
            "like_count": 9,
            "quote_count": 1,
            "reply_count": 4,
            "retweet_count": 1
        },
        "text": "Up to 50% of genetically validated targets will require completely new types of drugs \u2013 and new technologies to discover them. Go #BehindTheScience to learn more about what we\u2019re doing to become even more effective in finding medicines for patients. https://t.co/38nC4tEyuN"
    }
}